Jarosław Dróżdż - Researcher Profile

Publications

2 shown

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray , Scott D. Solomon , Silvio E. Inzucchi +35 more

BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through ...

2019 New England Journal of Medicine 6238 citations

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon , John J.V. McMurray , Brian Claggett +39 more

Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction....

2022 New England Journal of Medicine 2231 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 8,469
Institution: Medical University of Lodz

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-0732-2104

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.